RenovoRx, Inc.
Biotechnology · MOUNTAIN VIEW, CA
BiotechnologySEC Form D
RenovoRx, Inc. filed a Form D with the U.S. Securities and Exchange Commission on April 9, 2026, reporting $9,999,929 raised toward a $10,000,000 offering.
Incorporated in Delaware and based in MOUNTAIN VIEW, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that RenovoRx, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Shaun R. BagaiExecutive Officer · Director
- Mark VollExecutive Officer
- Leesa GentryExecutive Officer
- Ramtin AgahExecutive Officer
- Laurence J. MartonDirector
- Una S. RyanDirector
- Kirsten Angela MacfarlaneDirector
- Robert J. SpiegelDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised